CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Prospective, observational registry for subjects with GPP under the care of a dermatology investigator.Approximately 200 subjects and 75 clinical sites in North America will be recruited to participate with no defined upper limit for either target

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• A subject must meet all the following criteria to participate in the registry:

‣ Has been diagnosed with GPP by a dermatologist or a qualified dermatology practitioner.

⁃ Is at least 18 years of age and has attained the legal age for consent to procedures involved in the research, under the applicable law of the jurisdiction in which the research is being conducted.

⁃ Is willing to provide consent for participation in the registry.

⁃ Is willing to provide Personal Information

Locations
United States
Massachusetts
CorEvitas, LLC
RECRUITING
Waltham
Contact Information
Primary
Cathy Cheney
corevitasregistrytrials@corevitas.com
+1 508 408 5433
Backup
Jeffrey Greenberg, MD
Time Frame
Start Date: 2023-09-19
Estimated Completion Date: 2099-12
Participants
Target number of participants: 200
Treatments
Generalized Pustular Psoriasis (GPP)
Pts presenting to enrolling sites across the North America are invited to enroll if eligible
Sponsors
Leads: CorEvitas

This content was sourced from clinicaltrials.gov